TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II
about
Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancerOptimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PKATM, the Mre11/Rad50/Nbs1 complex, and topoisomerase I are concentrated in the nucleus of Purkinje neurons in the juvenile human brainCharacterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formationEmerging roles of the nucleolus in regulating the DNA damage response: the noncanonical DNA repair enzyme APE1/Ref-1 as a paradigmatical exampleTDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivoTyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damageProcessing of damaged DNA ends for double-strand break repair in mammalian cellsBRCA1: a novel prognostic factor in resected non-small-cell lung cancerIdentification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assayMitotic chromosomes are constrained by topoisomerase II-sensitive DNA entanglements.The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivityPharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsHuman Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages.Neurological disorders associated with DNA strand-break processing enzymes.Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors.Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitorsStructure-function studies of a plant tyrosyl-DNA phosphodiesterase provide novel insights into DNA repair mechanisms of Arabidopsis thalianaTyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1.Repair of topoisomerase I-mediated DNA damage.Tyrosyl-DNA phosphodiesterase as a target for anticancer therapyWRN protects against topo I but not topo II inhibitors by preventing DNA break formationBacterial topoisomerase I as a target for discovery of antibacterial compounds.Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecanAdaptation of topoisomerase I paralogs to nuclear and mitochondrial DNA.4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.Topoisomerase I as a biomarker: detection of activity at the single molecule level.Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target.Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecanIdentification of a putative Tdp1 inhibitor (CD00509) by in vitro and cell-based assays.Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses.TDP1 promotes assembly of non-homologous end joining protein complexes on DNA.TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to Topotecan.Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan.Dysregulated human Tyrosyl-DNA phosphodiesterase I acts as cellular toxin.
P2860
Q24298259-D0C67B83-2DB0-40A6-AA87-F5E5E837C3B0Q24311803-CF5F21FD-9F57-46F9-A991-5A76668EA9C5Q24318465-EADD4FFE-696D-40C6-9FEF-6EB760A5EB80Q24644674-D61AF0A9-7D4D-445F-9326-A83FCA02A759Q24655003-1CC67218-B85E-4AD6-BF83-F3D430E500A8Q24681546-89D88123-9394-422B-8B0A-B286D166FC09Q27026649-09613CC1-085A-44F6-8B66-363157E178A2Q27325200-BF1E1085-3D41-463B-B36E-C0C73C7D2094Q27934837-0915EA5E-79DD-487D-A5FF-D508FB301A08Q28000148-34FDB46B-BF07-4380-9679-0111A510645DQ33305206-7545BA7E-35D9-4E84-B322-DB050FB63854Q33399360-E128C5C7-D70C-40F8-BA04-6D59F211BACBQ33717052-7B5DF84F-F4E2-4894-85AE-23606E405918Q33783186-C57C2A38-E53E-45F4-BB5A-F6114D95BB12Q33854172-410D5318-5FF9-42CE-A40B-40296D5C2C42Q34008793-F799AB50-67C9-45F7-8C8A-E9BDFCC74376Q34312801-AFDBCC6D-AC90-4E6D-A286-C6B23418E1FBQ34535722-5DFBA8EA-61D0-4E43-A4B3-16A65DF4A23DQ35122653-A2F31076-0F09-49CE-B26B-8A9B221EEA6EQ35167579-B961970B-1EFF-4BC8-943C-776E83E74DD7Q35832629-EBD7D4D7-EDE3-45E9-ABB2-E6B9D51BCCC0Q35921514-7E2D22B5-AF5F-4E17-A833-1683020971DDQ35954578-D0D12CAD-4BF2-4B2E-B57D-331693C4109DQ36280725-A987E36B-EBB0-4736-BC85-5D4731FDF0DAQ36557533-1AC30C55-837F-4EAA-87E9-83F845A3D6AFQ36744910-877E47DD-7B8E-462C-AF01-47470D3FDC18Q37021622-33B3F409-BC53-427A-ADB5-CBE9E58C6580Q37108422-5545BC6C-ED5E-43C0-92D0-5C19D0ACE8C4Q37356204-A5F43A9F-D339-4683-A024-E45B65C8E7C7Q37406087-BEFA9790-0BB8-4FF2-842C-F4E3C8F5222FQ37445367-AE431057-372E-4F5D-85D8-4977124F210FQ37588708-0601794B-98E9-4277-B5BF-8ADC65FB547EQ38261264-03392415-AB14-4AF9-9B24-DCD701B3EA40Q38927275-1E064D71-5C81-452E-8FCB-0DD4B8C2D4AAQ38966735-88E73196-1339-4EEF-8BF4-581092C830FCQ39782358-C99DBE9F-9145-49F5-9A94-C48F18380308Q41116917-39205D2E-6F0F-4B4A-89F3-98E874E4FC28Q41959085-67EB3F2A-FE8B-4D4B-8A93-F3558AB15F8FQ42065258-1C35A9FC-DC6D-4842-823D-85CAA387620AQ42316506-B87BF670-84CF-47A5-A555-FF0E9004B817
P2860
TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
TDP1 overexpression in human c ...... ted by topoisomerases I and II
@ast
TDP1 overexpression in human c ...... ted by topoisomerases I and II
@en
TDP1 overexpression in human c ...... ted by topoisomerases I and II
@nl
type
label
TDP1 overexpression in human c ...... ted by topoisomerases I and II
@ast
TDP1 overexpression in human c ...... ted by topoisomerases I and II
@en
TDP1 overexpression in human c ...... ted by topoisomerases I and II
@nl
prefLabel
TDP1 overexpression in human c ...... ted by topoisomerases I and II
@ast
TDP1 overexpression in human c ...... ted by topoisomerases I and II
@en
TDP1 overexpression in human c ...... ted by topoisomerases I and II
@nl
P2093
P2860
P356
P1476
TDP1 overexpression in human c ...... ted by topoisomerases I and II
@en
P2093
Christian Mielke
Hans U Barthelmes
Heidrun Interthal
Jeffrey J Pouliot
Michael Habermeyer
Morten O Christensen
P2860
P304
P356
10.1074/JBC.M405042200
P407
P577
2004-12-31T00:00:00Z